Cayuga Biotech
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
500 Eighth Avenue Front 01596 3, New Yor...Website
www.cayugabiotech.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Cayuga Biotech
Cayuga Biotech is focused on developing innovative therapies to address life-threatening hemorrhage by leveraging the body's natural ability to stop bleeding. The company aims to fill significant gaps in current treatment options for noncompressible hemorrhage and coagulation dysfunction, which are critical in emergency situations. With a total addressable market size of $25 billion and over 3.5 million annual treatment opportunities, Cayuga Biotech targets healthcare providers and patients affected by bleeding disorders. Their proprietary science and novel mechanisms of action are designed to meet the unmet needs in hemorrhage control.Explore more
Cayuga Biotech Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cayuga Biotech your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Cayuga Biotech has new funding data
Congratulate Masked Content for being promoted to Masked Content at Cayuga Biotech
Product Launch: Get notified when Cayuga Biotech launches new products
Click to see if Cayuga Biotech had a recent Job posting/layoffs
Cayuga Biotech, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check if Cayuga Biotech has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Cayuga Biotech recently announced quarterly report
Website visits: Recent activity has been detected on your website
Check out if Cayuga Biotech is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Cayuga Biotech
Compare insights from companies similar to Cayuga Biotech, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Cayuga Biotech is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Cayuga Biotech is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Cayuga Biotech.
Cayuga Biotech Tech Stack
A closer look at the technologies used by Cayuga Biotech
See more technologies
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
New Hire
Executive Move
Lateral Move
Executive Move
Damien Kudela, Chief Executive Officer, has assumed the role of Chief Scientific Officer.
Lateral Move
Executive Move
Cayuga Biotech News & Media
Cayuga Closes $8M Seed Funding
Novel Therapeutic for Life-Threatening Hemorrhage, CAY001, to Advance to Clinic NEW YORK, NY, UNITED STATES, December 11, 2025 /EINPresswire.com/ -- Cayuga Biotech, Inc., a company developing novel therapeutics to address life-threatening hemorrhage, …Full Data on Cayuga’s Novel Synthetic Compound in Stopping Life-Threatening Hemorrhage Shows Promise
PolyP-SNP Complex Has Potential to Restore Blood Clotting Under Most Dangerous Conditions of Traumatic Injury NEW YORK, NY, UNITED STATES, November 5, 2025 /EINPresswire.com/ -- Cayuga Biotech, Inc., a company developing novel therapeutics to address …Cayuga's CAY001 Significantly Increases Survival and Improves Bleeding Outcomes in Platelet Inhibitor-Related Bleeding
Data on CAY001, a First-in-Class, Polyphosphate (polyP)-Based Therapy, Show Promise in Bypassing P2Y12 Inhibition to Restore Normal Clotting Function NEW YORK, NY, UNITED STATES, March 29, 2025 /EINPresswire.com/ -- Cayuga Biotech, a company that …Cayuga's poly-P-SNP Complex Demonstrates >90% Shorter Bleeding Time and Nearly 60% Less Blood Loss After Severe Injury
-- Data on Novel Synthetic Short-Chain Polyphosphate (polyP) Complexed with Silica Nanoparticle (SNP) Presented at 66th ASH Annual Meeting -- NEW YORK, NY, UNITED STATES, December 9, 2024 /EINPresswire.com/ -- Cayuga Biotech, a company that develops …
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Cayuga Biotech
Sign Up For FreeTo access detailed company insights
Cayuga Biotech is focused on developing innovative therapies to address life-threatening hemorrhage by leveraging the body's natural ability to stop bleeding. The company aims to fill significant gaps in current treatment options for noncompressible hemorrhage and coagulation dysfunction, which are critical in emergency situations. With a total add... Read More
